Neue Suche | Kongressdetail
Druckansicht
 
 

Oncolytic Virotherapy Summit 2017

evvnt Platform / evvnt
Kongressthemen
The Oncolytic Virotherapy Summit will gather the leaders in immuno-oncolytic virus development to discuss the most up-to-date clinical advances alongside novel innovations being made through the genetic modification of viruses.

Map out the route to market focusing on the strategic advancements needed to improve viral manufacturing yield and scale along with the operational and logistical aspects of delivering oncolytic virotherapies to patients in need.
Kongressorganizer (PCO)
Hanson Wade
Anmerkungen
Brochure: https://go.evvnt.com/158062-1

Speakers: Matt Mulvey (Benevir Biopharm), Charles Morris (PsiOxus Therapeutics), Stephen Thorne (Western Oncolytics), Frank Tufaro (DNAtrix), Stephen Russell (Vyriad), Angelica Loskog (Lokon Pharma)
 

Anfragen und Anmeldung:

http://go.evvnt.com/158062-0
Herr Customer Services
44 203 1418700
 
Kategorien
Onkologie
Sprache
Englisch
Kongressgebühr
USD 3.797,00
(Conference Earlybird (Book by 29/09/17): USD 1999, Conference + 1 Workshop Earlybird (Book by 29/09/17): USD 2498, Conference + 2 Workshop Earlybird (Book by 29/09/17): USD 2997, Workshop only: USD 599, Conference (Standard rate): USD 2799)
Veranstalter Kontakt
83 Great Titchfield Street
W1W 6RH London
Großbritannien
Tel: +44 0207 3230 450
hello@evvnt.com
 
"GOING INTERNATIONAL fördert den Zugang zu Aus-, Fort- und Weiterbildung, unabhängig von sozialen, geographischen und nationalen Grenzen."

newTreeAnästhesie in Entwicklungsländern e. V.Österreichische Gesellschaft für Public HealthSwiss Tropical and Public Health InstituteAGEM - Arbeitsgemeinschaft Ethnomedizin e. V.AMREF - African Medical and Research FoundationCharité International AcademyEuropean Health Forum Gastein

Facebook

Sagen Sie uns Ihre professionelle Meinung

Zur Umfrage

Zur Umfrage